|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM258018895 |
003 |
DE-627 |
005 |
20231224184108.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2015 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.15844/pedneurbriefs-29-6-7
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0860.xml
|
035 |
|
|
|a (DE-627)NLM258018895
|
035 |
|
|
|a (NLM)26933587
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Millichap, J Gordon
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Clinical Features of NMDAR Ab-mediated Encephalitis
|
264 |
|
1 |
|c 2015
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 02.03.2016
|
500 |
|
|
|a Date Revised 29.09.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
520 |
|
|
|a Investigators from University of Oxford, Birmingham Children's Hospital, Guy's and St Thomas', London, UK, performed a prospective surveillance study in children with NMDAR-Ab-mediated neurological disease reported from Nov 2010 to Dec 2011
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Encephalitis
|
650 |
|
4 |
|a Immunoglobulin
|
650 |
|
4 |
|a NMDAR Ab
|
650 |
|
4 |
|a Plasma Exchange
|
650 |
|
4 |
|a Steroids
|
700 |
1 |
|
|a Millichap, John J
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Pediatric neurology briefs
|d 1997
|g 29(2015), 6 vom: 01. Juni, Seite 48
|w (DE-627)NLM098248251
|x 1043-3155
|7 nnns
|
773 |
1 |
8 |
|g volume:29
|g year:2015
|g number:6
|g day:01
|g month:06
|g pages:48
|
856 |
4 |
0 |
|u http://dx.doi.org/10.15844/pedneurbriefs-29-6-7
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 29
|j 2015
|e 6
|b 01
|c 06
|h 48
|